SCHEMBL7817566

SCHEMBL7817566

CC(C)C(=O)OOc1cccc(N2CCN(C(=O)c3cccs3)CC2)c1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.55
ALDH1A1 P00352 5/20 0.52
GAA P10253 3/20 0.52
LMNA P02545 2/20 0.52
ALOX12 P18054 1/20 0.52
KCNA5 P22460 1/20 0.52
KMT2A Q03164 1/20 0.50
KDM4E B2RXH2 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.47
THRB P10828 1/20 0.47
DCTPP1 Q9H773 1/20 0.46
POLB P06746 1/20 0.46
HTT P42858 1/20 0.46
CYP2C9 P11712 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7817420 0.83 ALDH1A1 (0.55) MAPTALDH1A1GAALMNAL3MBTL1
SCHEMBL7813660 0.82 MAPT (0.56) MAPTALDH1A1LMNAKMT2APOLB
SCHEMBL7811730 0.81 LMNA (0.50) MAPTALDH1A1LMNAHTT
SCHEMBL7811396 0.81 ALDH1A1 (0.44) MAPTALDH1A1LMNAKDM4EHTT
SCHEMBL9011142 0.80 MAPT (0.42) MAPTALDH1A1GAALMNAKCNA5
SCHEMBL7814074 0.80 SMN1; SMN2 (0.53) MAPTALDH1A1LMNAKMT2AKDM4E
SCHEMBL7811456 0.80 MAPT (0.49) MAPTALDH1A1LMNAHTT
SCHEMBL7814066 0.80 ALDH1A1 (0.54) MAPTALDH1A1GAALMNAKMT2A
SCHEMBL7813608 0.80 MAPT (0.57) MAPTALDH1A1LMNAHTT
SCHEMBL7810031 0.80 MAPT (0.49) MAPTALDH1A1GAALMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed